NCT05839210 Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
| NCT ID | NCT05839210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Non Hodgkin Lymphoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2023-04-26 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2023-04-26 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.
Eligibility Criteria
Inclusion Criteria: 1. 18 years of age or older 2. Any sex/gender 3. Able to provide consent 4. Able to read or understand English or Spanish 5. Diagnosis of untreated Non-Hodgkin or Hodgkin lymphoma, requiring at least 6 cycles of chemotherapy, being treated with one of the following therapies at discretion of PIs: 1. R-CHOP or R-CHOP-like regimen 2. BR 3. BV-AVD or ABVD or checkpoint inhibitor+AVD 6. ECOG Performance Status grade of \<2 a. PI approval needed if ECOG = 2 7. Approval from treating oncologist, confirmed via email or in writing 8. Delivery of chemotherapy treatments at one of the following institutions: 1. Sylvester Comprehensive Cancer Center (including satellite/network sites) 2. University of Miami Hospital/UHealth Tower 9. Internet access on a smart phone, tablet, or computer 10. Willing to be randomized to a Mediterranean diet/home-based physical activity intervention or waitlist-control group. Exclusion Criteria: 1. Individuals younger than 18 years of age 2. Unable to provide consent 3. Unable to read or understand English or Spanish 4. Any contraindication for diet change or exercising as determined by physician 5. Currently following a vegan or ketogenic diet, or consuming more than 5 servings of fruit and vegetables per day for the prior month 6. Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month 7. History of dementia or major psychiatric disease 8. History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure
Contact & Investigator
Tracy E Crane, Phd, RDN
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT05839210 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non Hodgkin Lymphoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05839210 currently recruiting?
Yes, NCT05839210 is actively recruiting participants. Contact the research team at tecrane@med.miami.edu for enrollment information.
Where is the NCT05839210 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT05839210 clinical trial?
NCT05839210 is sponsored by University of Miami. The principal investigator is Tracy E Crane, Phd, RDN at University of Miami. The trial plans to enroll 140 participants.